Suppr超能文献

肽基脯氨酰异构酶Pin1在肺动脉重塑中的病理作用

Pathologic role of peptidyl-prolyl isomerase Pin1 in pulmonary artery remodeling.

作者信息

Wu Caixia, Ha Yanping, Zou Yuan, Liao Xiaomin, Zhang Shuya, Zhang Xiaodian, Li Rujia, Xing Jingci, Jie Wei, Guo Junli, Li Jingquan, Shen Zhihua

机构信息

Department of Pathology & Pathophysiology, School of Basic Medicine Sciences, Guangdong Medical University Zhanjiang 524023, Guangdong, China.

Key Laboratory for Tropical Cardiovascular Diseases Research of Hainan Province, The First Affiliated Hospital of Hainan Medical University Haikou 571199, Hainan, China.

出版信息

Am J Transl Res. 2021 Oct 15;13(10):11162-11177. eCollection 2021.

Abstract

Peptidyl-prolyl isomerase Pin1 is crucial for cell proliferation, but its role in pulmonary artery remodeling (PAR) is unclear. In the present study, we aimed to evaluate the expression and contribution of Pin1 in PAR. Treatment with Pin1 inhibitor Juglone or Pin1-specific siRNAs ameliorated the expression of Pin1 and proliferating cell nuclear antigen (PCNA) in human pulmonary artery smooth muscle cells (PASMCs) , and Juglone treatment arrested the cell cycle at the G1 phase. Treatment with transforming growth factor β1 (TGF-β1) also enhanced Pin1 expression and PASMC proliferation. Immunohistochemical staining revealed that Pin1 and PCNA expression levels were increased and positively correlated with each other in PAR samples from humans and monocrotaline-treated Sprague-Dawley rats; these proteins were mainly localized in arteries undergoing remodeling, as well as inflammatory cells, and hyperplastic bronchial epithelial cells. Intraperitoneal injection of Juglone also led to morphologic and hemodynamic changes in PAR rats. Additionally, PAR rats displayed higher serum and lung TGF-β1 levels compared with controls, while administration of Juglone to PAR rats suppressed serum and lung TGF-β1 levels. The findings in this study suggest that TGF-β1 and Pin1 constitute a positive feedback loop, which plays an important role in the pathophysiology of PAR.

摘要

肽基脯氨酰异构酶Pin1对细胞增殖至关重要,但其在肺动脉重塑(PAR)中的作用尚不清楚。在本研究中,我们旨在评估Pin1在PAR中的表达及作用。用Pin1抑制剂胡桃醌或Pin1特异性小干扰RNA(siRNA)处理可改善人肺动脉平滑肌细胞(PASMCs)中Pin1和增殖细胞核抗原(PCNA)的表达,且胡桃醌处理使细胞周期停滞在G1期。用转化生长因子β1(TGF-β1)处理也可增强Pin1表达和PASMC增殖。免疫组织化学染色显示,在人类和用野百合碱处理的Sprague-Dawley大鼠的PAR样本中,Pin1和PCNA表达水平升高且呈正相关;这些蛋白主要定位于正在重塑的动脉、炎症细胞及增生的支气管上皮细胞中。腹腔注射胡桃醌也导致PAR大鼠出现形态学和血流动力学变化。此外,与对照组相比,PAR大鼠血清和肺组织中TGF-β1水平更高,而给PAR大鼠施用胡桃醌可抑制血清和肺组织中TGF-β1水平。本研究结果表明,TGF-β1和Pin1构成一个正反馈环,在PAR的病理生理学中起重要作用。

相似文献

1
Pathologic role of peptidyl-prolyl isomerase Pin1 in pulmonary artery remodeling.
Am J Transl Res. 2021 Oct 15;13(10):11162-11177. eCollection 2021.
4
Osthole inhibits cell proliferation by regulating the TGF-β1/Smad/p38 signaling pathways in pulmonary arterial smooth muscle cells.
Biomed Pharmacother. 2020 Jan;121:109640. doi: 10.1016/j.biopha.2019.109640. Epub 2019 Nov 25.
6
Involvement of prolyl isomerase PIN1 in the cell cycle progression and proliferation of hepatic oval cells.
Pathol Res Pract. 2017 Apr;213(4):373-380. doi: 10.1016/j.prp.2017.01.005. Epub 2017 Jan 18.
7
Inhibition of Pin1 alleviates myocardial fibrosis and dysfunction in STZ-induced diabetic mice.
Biochem Biophys Res Commun. 2016 Oct 7;479(1):109-15. doi: 10.1016/j.bbrc.2016.09.050. Epub 2016 Sep 12.
8
Pin1 induction in the fibrotic liver and its roles in TGF-β1 expression and Smad2/3 phosphorylation.
J Hepatol. 2014 Jun;60(6):1235-41. doi: 10.1016/j.jhep.2014.02.004. Epub 2014 Feb 13.
9
Expression and significance of pin1 in the wound healing.
Arch Dermatol Res. 2024 May 25;316(6):235. doi: 10.1007/s00403-024-03030-z.
10
Role of Pin1 in neointima formation: down-regulation of Nrf2-dependent heme oxygenase-1 expression by Pin1.
Free Radic Biol Med. 2010 Jun 15;48(12):1644-53. doi: 10.1016/j.freeradbiomed.2010.03.013. Epub 2010 Mar 20.

本文引用的文献

1
Emerging role of long non-coding RNAs in pulmonary hypertension and their molecular mechanisms (Review).
Exp Ther Med. 2020 Dec;20(6):164. doi: 10.3892/etm.2020.9293. Epub 2020 Oct 9.
2
Stem/Progenitor Cells and Pulmonary Arterial Hypertension.
Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):167-178. doi: 10.1161/ATVBAHA.120.315052. Epub 2020 Oct 8.
3
Keratin 1 attenuates hypoxic pulmonary artery hypertension by suppressing pulmonary artery media smooth muscle expansion.
Acta Physiol (Oxf). 2021 Feb;231(2):e13558. doi: 10.1111/apha.13558. Epub 2020 Sep 24.
4
Novel Molecular Mechanisms of Pulmonary Hypertension: A Search for Biomarkers and Novel Drug Targets-From Bench to Bed Site.
Oxid Med Cell Longev. 2020 May 22;2020:7265487. doi: 10.1155/2020/7265487. eCollection 2020.
6
Pulmonary Artery Hypertension Model in Rats by Monocrotaline Administration.
Methods Mol Biol. 2018;1816:233-241. doi: 10.1007/978-1-4939-8597-5_18.
7
Mesenchymal stem cell-derived microvesicles alleviate pulmonary arterial hypertension by regulating renin-angiotensin system.
J Am Soc Hypertens. 2018 Jun;12(6):470-478. doi: 10.1016/j.jash.2018.02.006. Epub 2018 Mar 15.
8
New Drugs, Therapeutic Strategies, and Future Direction for the Treatment of Pulmonary Arterial Hypertension.
Curr Med Chem. 2019;26(16):2844-2864. doi: 10.2174/0929867325666180201095743.
9
Endothelial dysfunction in pulmonary arterial hypertension: an evolving landscape (2017 Grover Conference Series).
Pulm Circ. 2018 Jan-Mar;8(1):2045893217752912. doi: 10.1177/2045893217752912. Epub 2017 Dec 28.
10
Peptidyl-prolyl isomerase Pin1 deficiency attenuates angiotensin II-induced abdominal aortic aneurysm formation in ApoE mice.
J Mol Cell Cardiol. 2018 Jan;114:334-344. doi: 10.1016/j.yjmcc.2017.12.006. Epub 2017 Dec 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验